1. Home
  2. EZRA vs CDT Comparison

EZRA vs CDT Comparison

Compare EZRA & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Global Group Inc. Common Stock

EZRA

Reliance Global Group Inc. Common Stock

N/A

Current Price

$0.19

Market Cap

2.4M

Sector

Finance

ML Signal

N/A

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$3.41

Market Cap

22.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZRA
CDT
Founded
2013
2019
Country
United States
United States
Employees
64
6
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
22.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EZRA
CDT
Price
$0.19
$3.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.0M
99.6K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$0.37
52 Week High
$0.39
$11.00

Technical Indicators

Market Signals
Indicator
EZRA
CDT
Relative Strength Index (RSI) 49.56 49.96
Support Level $0.16 $3.18
Resistance Level $0.23 $4.50
Average True Range (ATR) 0.02 0.97
MACD 0.00 -0.26
Stochastic Oscillator 47.95 19.61

Price Performance

Historical Comparison
EZRA
CDT

About EZRA Reliance Global Group Inc. Common Stock

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.

Share on Social Networks: